把冷瘤变成热瘤来点燃免疫疗法
Yuan-Tong Liu1,2, Yun-Long Wang1,3, Shuo Wang1,2
1State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
了解抵抗免疫治疗的"冷"瘤是关键. 通过修改瘤微环境 (TME),将这些瘤转化为"热"瘤的策略对于提高癌症免疫疗法的有效性至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物材料科学 生物材料科学
背景情况:
- 癌症免疫疗法,特别是免疫检查点抑制剂 (ICI),有效性受到瘤微环境 (TME) 的严重影响.
- 瘤被分类为以下几种:
- 热的热的热的热的热的热.
- 寒冷的冷冷的冷冷的冷冷的冷冷的
- 基于免疫细胞透和TME特征,影响ICI疗效.
- 感冒瘤,具有有限的免疫透和免疫抑制的TME,抵抗免疫疗法.
研究的目的:
- 综合审查基底的分子和细胞机制,以全面审查的分子和细胞机制.
- 寒冷的冷冷的冷冷的冷冷的冷冷的
- 瘤表型. 瘤的表型.
- 批判性地评估新兴的转换策略.
- 寒冷的冷冷的冷冷的冷冷的冷冷的
- 将瘤转化为其他瘤.
- 热的热的热的热的热的热.
- 瘤增强免疫疗法.
- 探索生物材料在TME调制中的作用,以改善免疫治疗结果.
主要方法:
- 关于瘤微环境,癌症免疫学和免疫治疗的现有文献的综述.
- 分析冷瘤中免疫逃避的分子和细胞机制 (伪装,胁迫,细胞保护).
- 对TME重编程的治疗策略的评估,包括基于生物材料的方法.
主要成果:
- 感冒瘤使用伪装,强迫和细胞保护机制来逃避免疫检测和抵抗免疫治疗.
- 新兴的策略侧重于将冷瘤转化为热瘤,以提高免疫疗法响应率.
- 生物材料在重塑TME以增强抗瘤免疫力方面表现有前途.
结论:
- 将冷瘤转化为热瘤是扩大癌症免疫治疗适用性的关键策略.
- 针对TME机制对于克服对免疫检查点抑制剂的耐药性至关重要.
- 对生物材料应用的进一步研究具有促进癌症免疫治疗的巨大潜力.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
相关概念视频
Tumor Immunotherapy
The Tumor Microenvironment
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
